To compare the effects of PPARα agonists on the progression of obesity, 6-week-old male wild type (WT) mice were fed HFD containing 0.00033% pemafibrate or 0.2% fenofibrate for 12 weeks (Figure 1A). Here, PPARA is linked to obesity disorder.